Irritable Bowel Syndrome Treatment Market 2020 Research and Developments Abbott Laboratories, Allergan Plc, Ardelyx Inc
The irritable bowel syndrome treatment market was valued at $1,071 million in 2018, and is estimated to reach at $2,012 million by 2026, registering a CAGR of 8.2% from 2019 to 2026.
View full press release